Head of JLABS EMEA, Johnson & Johnson Innovation
Prior to joining JLABS, Guenter was leading the Business Development Organization and the Mature Brands at Janssen – the pharmaceutical companies of Johnson & Johnson in EMEA - Europe Middle East and Africa incl. Russia and CIS. Guenter received his MD and PhD from the University of Heidelberg and his Master of Science from the University of Witten/Herdecke. He is board accredited in Internal Medicine and Haemostaseology and owns a Professorship at the University of Heidelberg. Since he moved into the pharmaceutical Industry in 2001, Guenter has held various national, regional and global Leadership positions in R&D, Medical and the Business, first at Eli Lilly and then at Merck KGaA until joining Janssen and Johnson & Johnson in 2007. Guenter is experienced in Business modeling, Licensing, Merger & Acquisitions, Science, Medical and Market access in Healthcare.
He privately supports start-up businesses as investor and entrepreneur and has founded Corevas® in 2015. Corevas® is a privately owned limited liability company developing EmergencyEye®, a potentially life-saving communication technology innovation for emergency case management launched at the end of 2018.